RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
The Role of Imaging in Relapse Detection During Follow up: a Fifteen-Year Single Center Experience.
2009-01-01 Pelosini, M; Caracciolo, F; Galimberti, Sara; Benedetti, E; Papineschi, Federico; Orciuolo, E; Buda, G; Petrini, Mario
THU0264 MYELOID MALIGNANCIES, SYSTEMIC AUTOIMMUNE DISEASES AND CARDIOVASCULAR RISK: AN UNDER-REPORTED ASSOCIATION?
2020-01-01 Ferro, F.; Baratè, C.; Elefante, E.; Ricci, F.; Balducci, S.; Governato, G.; Fulvio, G.; Mosca, M.; Petrini, M.; Galimberti, S.; Baldini, C.
TNF-a Polymorphism Modulates the Outcome of Multiple Myeloma Patients Treated with Bortezomib
2008-01-01 Buda, G; Martino, A; Maggini, V; Orciuolo, E; Galimberti, Sara; Gentile, M; Brunori, M; Morabito, F; Rossi, Am; Petrini, M.
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib
2014-01-01 Galimberti, Sara; L., Galeotti; F., Ceccherini; Ml, Polillo; C., Baratè; Fontanelli, Giulia; Guerrini, Francesca; Arici, Roberta; S., Barsotti; F., Ricci; L., Aprile; Cornolti, Fulvio; Petrini, Mario; M., Bocchia; DI PAOLO, Antonello
TTV VIREMIA IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: A NEW SURROGATE MARKER OF IMMUNE DYSFUNCTION?
2008-01-01 Focosi, Df; Maggi, M; Ricci, V; Albani, M; Rocchi, J; Matera, L; Lanini, L; Andreoli, E; Vatteroni, Ml; Pistello, Mauro; Bendinelli, M; CECCHERINI-NELLI, Luca; Petrini, Mario
TYROSINE KINASE INHIBITORS SIGNIFICANTLY CHANGE THE EXPRESSION OF POLYCOMB GENES IN CHRONIC MYELOID LEUKEMIA
2017-01-01 Grassi, S; Palumbo, S; Arrigoni, E; Ciabatti, E; Ercolano, G; Guerrini, F; Di Vita, A; Pacini, S; Montali, M; Barachini, S; Domenichini, C; Tarrini, G; Vangeli, M; Salehzadeh, S; Metelli, Mr; Pellegrini, S; Ricci, F; Barate, C; Mariotti, V; Petrini, M; Di Paolo, A; Galimberti, S
VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) POLYMORPHISMS AND THEIR RELATIONSHIP WITH CLINICAL OUTCOME OF MANTLE CELL LYMPHOMA
2009-01-01 Galimberti, Sara; Nagy, B; Palumbo, Ga; Buda, G; Orciuolo, E; Melosi, A; Lambelet, P; Petrini, Mario
VDTPACE As Salvage Therapy For Heavily Pretreated MM Patients
2013-01-01 Buda, Gabriele; E., Orciuolo; Galimberti, Sara; F., Ghio; Petrini, Mario
WT1 GENE EXPRESSION IS SIGNIFICANTLY INHIBITED BY VORINOSTAT AND BORTEZOMIB IN MYELOPROLIFERATIVE/MYELODISPLASTIC DISEASES
2007-01-01 Canestraro, M; Galimberti, Sara; Pacini, S; Fazzi, R; Mattii, Letizia; Battolla, B; Khan, R; Petrini, Mario
WT1 gene expression is significantly inhibited by vorinostat and bortezomib
2007-01-01 Galimberti, Sara; Canestraro, M; Khan, R.; Buda, G.; Orciuolo, E.; Guerrini, F.; Fazzi, R; Petrini, Mario
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
The Role of Imaging in Relapse Detection During Follow up: a Fifteen-Year Single Center Experience. | 1-gen-2009 | Pelosini, M; Caracciolo, F; Galimberti, Sara; Benedetti, E; Papineschi, Federico; Orciuolo, E; Buda, G; Petrini, Mario | |
THU0264 MYELOID MALIGNANCIES, SYSTEMIC AUTOIMMUNE DISEASES AND CARDIOVASCULAR RISK: AN UNDER-REPORTED ASSOCIATION? | 1-gen-2020 | Ferro, F.; Baratè, C.; Elefante, E.; Ricci, F.; Balducci, S.; Governato, G.; Fulvio, G.; Mosca, M.; Petrini, M.; Galimberti, S.; Baldini, C. | |
TNF-a Polymorphism Modulates the Outcome of Multiple Myeloma Patients Treated with Bortezomib | 1-gen-2008 | Buda, G; Martino, A; Maggini, V; Orciuolo, E; Galimberti, Sara; Gentile, M; Brunori, M; Morabito, F; Rossi, Am; Petrini, M. | |
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib | 1-gen-2014 | Galimberti, Sara; L., Galeotti; F., Ceccherini; Ml, Polillo; C., Baratè; Fontanelli, Giulia; Guerrini, Francesca; Arici, Roberta; S., Barsotti; F., Ricci; L., Aprile; Cornolti, Fulvio; Petrini, Mario; M., Bocchia; DI PAOLO, Antonello | |
TTV VIREMIA IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: A NEW SURROGATE MARKER OF IMMUNE DYSFUNCTION? | 1-gen-2008 | Focosi, Df; Maggi, M; Ricci, V; Albani, M; Rocchi, J; Matera, L; Lanini, L; Andreoli, E; Vatteroni, Ml; Pistello, Mauro; Bendinelli, M; CECCHERINI-NELLI, Luca; Petrini, Mario | |
TYROSINE KINASE INHIBITORS SIGNIFICANTLY CHANGE THE EXPRESSION OF POLYCOMB GENES IN CHRONIC MYELOID LEUKEMIA | 1-gen-2017 | Grassi, S; Palumbo, S; Arrigoni, E; Ciabatti, E; Ercolano, G; Guerrini, F; Di Vita, A; Pacini, S; Montali, M; Barachini, S; Domenichini, C; Tarrini, G; Vangeli, M; Salehzadeh, S; Metelli, Mr; Pellegrini, S; Ricci, F; Barate, C; Mariotti, V; Petrini, M; Di Paolo, A; Galimberti, S | |
VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) POLYMORPHISMS AND THEIR RELATIONSHIP WITH CLINICAL OUTCOME OF MANTLE CELL LYMPHOMA | 1-gen-2009 | Galimberti, Sara; Nagy, B; Palumbo, Ga; Buda, G; Orciuolo, E; Melosi, A; Lambelet, P; Petrini, Mario | |
VDTPACE As Salvage Therapy For Heavily Pretreated MM Patients | 1-gen-2013 | Buda, Gabriele; E., Orciuolo; Galimberti, Sara; F., Ghio; Petrini, Mario | |
WT1 GENE EXPRESSION IS SIGNIFICANTLY INHIBITED BY VORINOSTAT AND BORTEZOMIB IN MYELOPROLIFERATIVE/MYELODISPLASTIC DISEASES | 1-gen-2007 | Canestraro, M; Galimberti, Sara; Pacini, S; Fazzi, R; Mattii, Letizia; Battolla, B; Khan, R; Petrini, Mario | |
WT1 gene expression is significantly inhibited by vorinostat and bortezomib | 1-gen-2007 | Galimberti, Sara; Canestraro, M; Khan, R.; Buda, G.; Orciuolo, E.; Guerrini, F.; Fazzi, R; Petrini, Mario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 101
- 1 Contributo su Rivista::1.5 Abst... 101
Data di pubblicazione
- 2010 - 2020 48
- 2000 - 2009 49
- 1990 - 1999 4
Rivista
- BLOOD 35
- HAEMATOLOGICA 33
- BONE MARROW TRANSPLANTATION 13
- HAEMATOLOGICA 7
- BONE MARROW TRANSPLANTATION 4
- AMERICAN JOURNAL OF CLINICAL ONCO... 2
- ANNALS OF THE RHEUMATIC DISEASES 1
- BLOOD REVIEWS 1
- CYTOMETRY. PART A 1
- EUROPEAN SURGICAL RESEARCH 1
Keyword
- immune reconstitution 3
- immunotherapy 2
- T-lymphocytes 2
- thymus 2
- zinc 2
- 10 patients died all due to progr... 1
- 27 a partial remission considerin... 1
- 28 with 70 mg/m2 and 5 with 120 m... 1
- 3 relapsed and 28 with disease un... 1
- 31 in continuous complete remission 1
Lingua
- eng 71
Accesso al fulltext
- no fulltext 96
- open 4
- restricted 1